---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018955"
form_type: "8-K"
ticker: "NXGL"
cik: "0001468929"
company_name: "NEXGEL, INC."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T02:10:13.269473+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NEXGEL Q1 revenue $1.27M (+104% YoY); net loss $905K vs $807K YoY

## Summary
- Revenue increased 104% to $1.27M, driven by contract manufacturing (+58%) and branded products (+178%).
- Gross profit turned positive to $277K from a loss of $57K YoY; gross margin 21.9% vs negative 9.2%.
- Net loss widened to $905K from $807K; SG&A up 43.8% to $1.1M on higher advertising and consulting costs.
- Cash balance $2.4M as of March 31, 2024, including ~$1M insider-led registered direct offering.
- Capacity expansion in Texas nearly complete; product launches with Abbvie and European market entry expected.

## SEC filing metadata
- accession: 0001493152-24-018955
- form_type: 8-K
- ticker: NXGL
- cik: 0001468929
- company_name: NEXGEL, INC.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468929/000149315224018955/0001493152-24-018955-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468929/000149315224018955/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018955
- JSON: https://secwatch.observer/filing/0001493152-24-018955.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018955.txt

## Key facts
- Earnings Releases
  NEXGEL, INC. reported the quarter ended March 31, 2024 results: revenue $1.27 million, net income $905,000.
  - Period: the quarter ended March 31, 2024
  - Revenue: $1.27 million
  - Net income: $905,000
  - Result: reported results
  source text: as shall be expressly set forth by specific reference in such a filing. --- EX-99.1 () --- EX-99.1 2 ex99-1.htm Exhibit 99.1 NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year LANGHORNE, Pa. – May 13, 2024 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468929/000149315224018955/0001493152-24-018955-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.